1. Home
  2. DNUT vs ZLAB Comparison

DNUT vs ZLAB Comparison

Compare DNUT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$4.58

Market Cap

734.9M

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$17.97

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
ZLAB
Founded
1937
2013
Country
United States
China
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
734.9M
2.0B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
DNUT
ZLAB
Price
$4.58
$17.97
Analyst Decision
Buy
Buy
Analyst Count
6
6
Target Price
$6.22
$57.22
AVG Volume (30 Days)
3.1M
1.0M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
1.53%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,534,272,000.00
$441,629,000.00
Revenue This Year
N/A
$30.20
Revenue Next Year
$0.77
$34.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.14
52 Week Low
$2.50
$16.82
52 Week High
$10.06
$44.34

Technical Indicators

Market Signals
Indicator
DNUT
ZLAB
Relative Strength Index (RSI) 59.61 31.02
Support Level $4.35 $16.82
Resistance Level $4.75 $18.67
Average True Range (ATR) 0.19 0.60
MACD 0.01 0.13
Stochastic Oscillator 70.92 33.24

Price Performance

Historical Comparison
DNUT
ZLAB

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: